Jennifer H Yearley

Jennifer H Yearley

UNVERIFIED PROFILE

Are you Jennifer H Yearley?   Register this Author

Register author
Jennifer H Yearley

Jennifer H Yearley

Publications by authors named "Jennifer H Yearley"

Are you Jennifer H Yearley?   Register this Author

30Publications

1411Reads

25Profile Views

Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma.

J Thorac Oncol 2018 08 24;13(8):1204-1212. Epub 2018 Apr 24.

Division of Medical Oncology, Department of Internal Medicine, Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.04.013DOI Listing
August 2018

Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue.

Arch Pathol Lab Med 2016 Nov;140(11):1259-1266

From the Departments of Molecular Biomarkers and Diagnostics (Drs Dolled-Filhart, Pierce, Weiner, Wu, and Emancipator) and Profiling and Expression (Dr Yearley), Merck & Co, Inc, Kenilworth, New Jersey; the Departments of Early Clinical & Translational Research, Clinical Histochemistry (Dr Locke), Research and Clinical Client Services (Dr Murphy), and Operations and Client Services (Dr Lynch), QualTek Molecular Laboratories, Newtown, Pennsylvania; and the Department of Pathology, Eisenhower Medical Center, Rancho Mirage, California (Dr Frisman). Dr Locke is now with Bristol-Myers Squibb, Princeton, New Jersey; Dr Pierce is now with OncoSec Medical, Inc, San Diego, California; Dr Weiner is now with Daiichi Sankyo, Edison, New Jersey; and Dr Wu is currently at Janssen Research & Development, Spring House, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0544-OADOI Listing
November 2016

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

N Engl J Med 2016 Jun 19;374(26):2542-52. Epub 2016 Apr 19.

From the University of Washington Medical Center (P.T.N., S. Bhatia, N.J.M., E.M.S., M.M.S., J.A.T., M.A.C.), Fred Hutchinson Cancer Research Center (P.T.N., S. Bhatia, S.P.F., L.L., J.A.T., M.A.C.), Cancer Immunotherapy Trials Network (S.P.F., L.L., M.A.C.), and Cancer Research and Biostatistics (A.M., L.R.S.) - all in Seattle; Johns Hopkins University School of Medicine and Kimmel Cancer Center, Baltimore (E.J.L., S. Berry, D.M.P., W.H.S., J.C.S., J.M.T., S.L.T.), and Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda. (E.S.) - both in Maryland; Winship Cancer Institute of Emory University, Atlanta (R.R.K.); Merck Research Laboratories, Kenilworth, NJ (L.A., E.K.C., S.M.T., J.H.Y.); University of California, San Francisco, San Francisco (A.D.), and Stanford University, Stanford (H.E.K., K.M., S.A.R.) - both in California; Mt. Sinai Medical Center, New York (P.A.F.); Yale University, New Haven, CT (H.M.K.); and Ohio State University, Columbus (T.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927341PMC
June 2016

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

Lung Cancer 2015 Aug 18;89(2):181-8. Epub 2015 May 18.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.007DOI Listing
August 2015

PD-L1 Expression and Tumor-Infiltrating Lymphocytes Define Different Subsets of MAPK Inhibitor-Treated Melanoma Patients.

Clin Cancer Res 2015 Jul 21;21(14):3140-8. Epub 2015 Jan 21.

Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2023DOI Listing
July 2015

PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.

Pigment Cell Melanoma Res 2015 May 22;28(3):245-53. Epub 2014 Dec 22.

Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pcmr.12340
Publisher Site
http://dx.doi.org/10.1111/pcmr.12340DOI Listing
May 2015

Tissue-specific reduction in DC-SIGN expression correlates with progression of pathogenic simian immunodeficiency virus infection.

Dev Comp Immunol 2008 9;32(12):1510-21. Epub 2008 Jul 9.

Division of Comparative Pathology, New England Primate Research Center, Harvard Medical School, One Pine Hill Dr. P.O. Box 9102, Southborough, MA 01772, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dci.2008.06.006DOI Listing
November 2008

Phagocytic plasmacytoma in a dog.

Vet Clin Pathol 2007 Sep;36(3):293-6

Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.

View Article

Download full-text PDF

Source
September 2007

Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease.

AIDS Res Hum Retroviruses 2007 Apr;23(4):515-24

Graduate School of Biomedical Sciences, University of Massachusetts, Worcester, MA 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2006.0211DOI Listing
April 2007

SIV-associated myocarditis: viral and cellular correlates of inflammation severity.

AIDS Res Hum Retroviruses 2006 Jun;22(6):529-40

University of Massachusetts, Graduate School of Biomedical Sciences, Worcester, Massachusetts 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2006.22.529DOI Listing
June 2006

Survival time, lifespan, and quality of life in dogs with idiopathic Fanconi syndrome.

J Am Vet Med Assoc 2004 Aug;225(3):377-83

New England Primate Research Center, Harvard Medical School, Division of Comparative Pathology, One Pine Hill Dr, PO Box 9102, Southborough, MA 01772, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2460/javma.2004.225.377DOI Listing
August 2004